Aurinia Pharmaceuticals (AUPH) Reports In-Line Q2 EPS, narrows guidance

Go back to Aurinia Pharmaceuticals (AUPH) Reports In-Line Q2 EPS, narrows guidance
(NASDAQ: AUPH) Delayed: 16.10 -0.01 (0.06%)
Previous Close $16.11    52 Week High $5.69 
Open $16.28    52 Week Low $1.42 
Day High $16.35    P/E N/A 
Day Low $16.06    EPS $0.00 
Volume 745,430